Please Wait.....
Report
Germany Biotechnology Market Report and Forecast 2025-2034
Market Report I 2025-06-20 I 250 Pages I EMR Inc.
The Germany biotechnology market was valued at USD 35.30 Billion in 2024, driven by the strong public and private investment in biotech innovation and R&D, supported by well-established academic and research institutions across the region. The market is anticipated to grow at a CAGR of 10.30% during the forecast period of 2025-2034, with the values likely to reach USD 94.09 Billion by 2034. Favorable government initiatives and funding accelerate the development and commercialization of advanced biotechnological solutions. The market growth is also characterized by robust infrastructure, high R&D capacity, and a skilled workforce. Increasing adoption of precision medicine and biopharmaceuticals will support growth in the forecast period.
Germany Biotechnology Market Overview
Biotechnology is the application of biological systems, organisms, or derivatives to develop or modify products and processes for specific use in healthcare, agriculture, and industry. It integrates molecular biology, genetics, and biochemistry disciplines to innovate solutions for global challenges. The biotechnology market in Germany demonstrates strong growth driven by advanced research infrastructure, government support, and increasing demand for biopharmaceuticals and diagnostics. The country is a key hub for European biotechnology innovation, with a high concentration of biotech companies and research institutions. The market was valued at USD 35.30 Billion in 2024.
Germany Biotechnology Market Growth Drivers
Increasing Prevalence of Chronic Diseases to Elevate the Market Growth
The rising incidence of chronic and degenerative diseases remains a significant growth driver in the market. According to the World Health Organization 2021 data, ischemic heart disease led mortality rates, with 220.6 deaths per 100,000 males and 189.9 per 100,000 females. Other major causes include Alzheimer's disease, stroke, cancers, chronic obstructive pulmonary disease, and kidney disorders. This persistent health burden has heightened the demand for innovative diagnostics, targeted therapies, and precision medicine, areas where biotechnology plays a pivotal role. As public and private sectors increase investment in research and development, the market is expected to grow steadily, supported by the urgent need for advanced healthcare solutions.
Germany Biotechnology Market Trends
The market is experiencing trends such as rising investments and the emergence of innovative, sustainable technologies.
Increasing Investments to Drive Market Growth
The market is experiencing a rise in investments, reflecting growing confidence in innovative biotechnologies and their commercial potential. For instance, in January 2025, BIO Deutschland and EY reported that funding for German biotech companies increased by 78% year-over-year, reaching EUR 1.917 billion in 2024. This surge is driven by higher venture capital investments, public equity raises, and initial public offerings, marking a record level of funding outside the pandemic period. The sustained increase in capital inflows highlights expanding opportunities and is expected to accelerate market growth and technological advancement.
Introduction of Innovative, Sustainable Food Technologies to Elevate the Germany Biotechnology Market Demand
The introduction of innovative, sustainable food technologies is a significant trend driving growth in the market. In March 2024, Kynda, a pioneering biotech company, launched Europe's first zero-waste mycelium-based food product in Germany. The "Kynda meat" burger offers a highly nutritious and environmentally friendly alternative to traditional protein sources by using efficient fermentation and sustainable raw materials. This advancement reflects the increasing industry focus on eco-conscious solutions to meet rising consumer demand. This innovation is expected to accelerate market growth and broaden the adoption of sustainable biotech products across Germany.
Germany Biotechnology Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
- Instruments
- Reagents
- Software and Services
- Others
Market Breakup by Technology
- Nanobiotechnology
- Tissue Engineering and Regeneration
- DNA Sequencing
- Cell-based Assays
- Fermentation
- PCR Technology
- Chromatography
- Others
Market Breakup by Application
- Health
- Food & Agriculture
- Natural Resources & Environment
- Industrial Processing
- Bioinformatics
- Others
Germany Biotechnology Market Share
DNA Sequencing Poised to Revolutionize the Germany Biotechnology Market Growth
The biotechnology market in Germany encompasses diverse technologies, including nanobiotechnology, tissue engineering and regeneration, DNA sequencing, cell-based assays, fermentation, PCR technology, chromatography, and others. Among these, DNA sequencing is expected to take the lead. The growth of this sector is driven by groundbreaking innovations like Merck's Aptegra platform. Launched in April 2024, this next-generation sequencing technology streamlines biosafety testing by combining five assays into one, cutting testing time by 66% costs by 43%. As regulatory bodies increasingly embrace such efficient solutions, DNA sequencing stands at the forefront, reshaping biotech workflows and fueling the market's future growth in Germany.
Leading Players in the Germany Biotechnology Market
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
QIAGEN N.V.
QIAGEN N.V., established in 1984 and headquartered in Venlo, Netherlands, is a key player in the biotechnology market with a strong presence in Germany. In May 2025, QIAGEN enhanced its clinical genomics portfolio by acquiring Genoox, an AI-powered software company. This acquisition adds the Franklin platform, which offers advanced AI-driven genetic data interpretation, supporting clinical decision-making in genetic disorders and cancer treatments.
Thermo Fisher Scientific, Inc.
Headquartered in Waltham, Massachusetts, Thermo Fisher Scientific is a leading company in the biotechnology sector. In March 2025, it introduced sustainable large-capacity centrifuges, Cryofuge, BIOS, and LYNX, produced at its zero-waste facility in Osterode am Harz, Germany. These centrifuges enhance bioprocessing, blood banking, and research with improved energy efficiency and compliance with European environmental standards, reinforcing Thermo Fisher's dedication to sustainable biotechnology.
Illumina Inc.
Illumina Inc. is a global leader in DNA sequencing and genomic technologies. It was established in 1998 and is headquartered in San Diego, California. In May 2025, Illumina partnered with Ovation.io to launch the largest clinical multiomic GLP-1 dataset from 25,000 patients, accelerating the development of novel therapies and biomarkers in metabolic diseases. This initiative supports advancements in the biotechnology market.
F. Hoffman-La Roche Ltd.
Headquartered in Basel, Switzerland, and established in 1896, F. Hoffman-La Roche Ltd. is a leading biotechnology company. In January 2025, the company received FDA clearance for its highly sensitive VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail assay. This test aids in accurately diagnosing B-cell lymphoma, enhancing clinical decision-making and patient outcomes in hematopathology.
Other key players in the market include Evotec SE, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., and BioNTech SE.
Key Questions Answered in the Germany Biotechnology Market Report
- What was the Germany biotechnology market value in 2024?
- What is the Germany biotechnology market forecast outlook for 2025-2034?
- What are the major factors aiding the Germany biotechnology market demand?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- What are the major Germany biotechnology market trends?
- Which product is expected to dominate the market segment?
- Which technology is projected to lead the market segment?
- Which application is anticipated to drive the market segment?
- Who are the key players involved in the Germany biotechnology market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Biotechnology Market Overview
3.1 Europe Biotechnology Market
3.1.1 Europe Biotechnology Market Historical Value (2018-2024)
3.1.2 Europe Biotechnology Market Forecast Value (2025-2034)
3.2 Germany Biotechnology Market
3.2.1 Germany Biotechnology Market Historical Value (2018-2024)
3.2.2 Germany Biotechnology Market Forecast Value (2025-2034)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Germany Biotechnology Market Landscape
5.1 Germany Biotechnology Market: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Germany Biotechnology Market: Product Landscape
5.2.1 Analysis by Product Type
5.2.2 Analysis by Technology
5.2.3 Analysis by Application
6 Germany Biotechnology Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter's Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Germany Biotechnology Market Segmentation (218-2034)
7.1 Germany Biotechnology Market (2018-2034) by Product Type
7.1.1 Market Overview
7.1.2 Instruments
7.1.3 Reagents
7.1.4 Software and Services
7.1.5 Others
7.2 Germany Biotechnology Market (2018-2034) by Technology
7.2.1 Market Overview
7.2.2 Nanobiotechnology
7.2.3 Tissue Engineering and Regeneration
7.2.4 DNA Sequencing
7.2.5 Cell-based Assays
7.2.6 Fermentation
7.2.7 PCR Technology
7.2.8 Chromatography
7.2.9 Others
7.3 Germany Biotechnology Market (2018-2034) by Application
7.3.1 Market Overview
7.3.2 Health
7.3.3 Food & Agriculture
7.3.4 Natural Resources & Environment
7.3.5 Industrial Processing
7.3.6 Bioinformatics
7.3.7 Others
8 Regulatory Framework
9 Patent Analysis
9.1 Analysis by Type of Patent
9.2 Analysis by Publication Year
9.3 Analysis by Patent Age
9.4 Analysis by CPC Analysis
9.5 Analysis by Patent Valuation
10 Funding and Investment Analysis
10.1 Analysis by Funding Instances
10.2 Analysis by Type of Funding
10.3 Analysis by Funding Amount
10.4 Analysis by Leading Players
10.5 Analysis by Leading Investors
10.6 Analysis by Geography
11 Strategic Initiatives
11.1 Analysis by Partnership Instances
11.2 Analysis by Type of Partnership
11.3 Analysis by Leading Players
11.4 Analysis by Geography
12 Supplier Landscape
12.1 Market Share Analysis, By Country
12.2 BioNTech SE
12.2.1 Financial Analysis
12.2.2 Product Portfolio
12.2.3 Demographic Reach and Achievements
12.2.4 Company News and Developments
12.2.5 Certifications
12.3 Evotec SE
12.3.1 Financial Analysis
12.3.2 Product Portfolio
12.3.3 Demographic Reach and Achievements
12.3.4 Company News and Developments
12.3.5 Certifications
12.4 QIAGEN N.V.
12.4.1 Financial Analysis
12.4.2 Product Portfolio
12.4.3 Demographic Reach and Achievements
12.4.4 Company News and Developments
12.4.5 Certifications
12.5 Thermo Fisher Scientific, Inc.
12.5.1 Financial Analysis
12.5.2 Product Portfolio
12.5.3 Demographic Reach and Achievements
12.5.4 Company News and Developments
12.5.5 Certifications
12.6 Illumina Inc.
12.6.1 Financial Analysis
12.6.2 Product Portfolio
12.6.3 Demographic Reach and Achievements
12.6.4 Company News and Developments
12.6.5 Certifications
12.7 F. Hoffman-La Roche Ltd.
12.7.1 Financial Analysis
12.7.2 Product Portfolio
12.7.3 Demographic Reach and Achievements
12.7.4 Company News and Developments
12.7.5 Certifications
12.8 Bio-Rad Laboratories, Inc.
12.8.1 Financial Analysis
12.8.2 Product Portfolio
12.8.3 Demographic Reach and Achievements
12.8.4 Company News and Developments
12.8.5 Certifications
12.9 Agilent Technologies, Inc.
12.9.1 Financial Analysis
12.9.2 Product Portfolio
12.9.3 Demographic Reach and Achievements
12.9.4 Company News and Developments
12.9.5 Certifications
13 Germany Biotechnology Market - Distribution Model (Additional Insight)
13.1 Overview
13.2 Potential Distributors
13.3 Key Parameters for Distribution Partner Assessment
14 Key Opinion Leaders (KOL) Insights (Additional Insight)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security